David J Horin - Net Worth and Insider Trading

David J Horin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, David J Horin owns 3 companies in total, including Mustang Bio Inc (MBIO) , Checkpoint Therapeutics Inc (CKPT) , and Protagenic Therapeutics Inc (PTIX) .

Click here to see the complete history of David J Horin’s form 4 insider trades.

Insider Ownership Summary of David J Horin

Ticker Comapny Transaction Date Type of Owner
MBIO Mustang Bio Inc 2016-09-26 Interim CFO
CKPT Checkpoint Therapeutics Inc 2016-09-09 Interim CFO
PTIX Protagenic Therapeutics Inc 2014-09-02 Chief Financial Officer

David J Horin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

David J Horin Ownership Network

Ownership Network List of David J Horin

No Data

Ownership Network Relation of David J Horin


David J Horin Owned Company Details

What does Mustang Bio Inc do?

Who are the key executives at Mustang Bio Inc?

David J Horin is the Interim CFO of Mustang Bio Inc. Other key executives at Mustang Bio Inc include 10 percent owner Fortress Biotech, Inc. , director & President and CEO Manuel Md Litchman , and Interim CFO Eliot M Lurier .

Mustang Bio Inc (MBIO) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Mustang Bio Inc (MBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Mustang Bio Inc (MBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Mustang Bio Inc (MBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Mustang Bio Inc Insider Transactions

No Available Data

David J Horin Mailing Address

Above is the net worth, insider trading, and ownership report for David J Horin. You might contact David J Horin via mailing address: 1270 Avenue Of The Americas, 16th Floor, New York Ny 10020.

Discussions on David J Horin

No discussions yet.